Navigation Links
New Drug Promises Prolonged Survival in Prostate Cancer Patients

A new anti-cancer drug called pertuzumab, shows promise in slowing progression and prolonging survival time in men with prostate cancer.//

A new class of targeted anti-cancer drugs that blocks the human epidermal growth factor (HER) receptor family shows promise in prolonging the lives of patients with recurrent prostate cancer, a new Cedars-Sinai study shows. The drug, a molecular targeted compound called pertuzumab, works by binding to and inhibiting the function of HER2 receptors, interrupting a key pathway that leads to cancer growth.

The study, published in the February 20 issue of the Journal of Clinical Oncology, involved 41 patients with treatment-resistant prostate cancer who had experienced progression of their disease after prior chemotherapy. Patients received the drug every three weeks until disease progression. MRI and CAT scans were used to evaluate the tumors during the period of drug therapy. While no shrinkage of tumors was reported, retrospective analysis showed that survival rate was prolonged to 16.4 months with the drug as compared to a median average of 10.7 months in a historical control group with similar baseline prognostic features.

“Advanced prostate cancer is difficult to treat – and the drug therapies currently available to these patients have not been very effective, especially in patients whose disease has progressed after chemotherapy treatment,” said David B. Agus, M.D., principal investigator of the study and research director of Cedars-Sinai’s Louis Warschaw Prostate Cancer Center at the Samuel Oschin Comprehensive Cancer Institute. “Pertuzumab may offer a new treatment approach for these patients when it is evaluated as a tool to slow – not stop or shrink -- tumor growth.”

“The theory is that by significantly slowing progression of the cancer, patients will experience a good quality of life for a longer period of time,” said Agus. “Ultimately, we hope drugs like pertuzumab will help
'"/>




Page: 1 2 3

Related medicine news :

1. Marijuana-Derived Drug Promises Hope In Treating Bladder Infection
2. LINK Applied Genomics Programme Promises To Revolutionize Healthcare Systems
3. Diarrhea Vaccine Trials Promises Prevention of Rotavirus Infection
4. Maternal Vitamin D Supplementation Promises Healthy Bones In Child
5. Raw Vegan Diet Promises Lightweight, Healthy Bones
6. Stem Cell Transplantation Promises Cure for Type 2 Diabetes
7. New Drug Promises Hope In Multiple Drug Resistant And Latent TB Treatment
8. Health Minister Promises Strict Quality Control On Herbal Medicines
9. Anti-Cancer Treatment Promises Hope in Bird Flu Treatment
10. Nanotechnology Promises Huge Medical Benefits
11. Health Minister Promises New Benchmark for Wait Times
Post Your Comments:
(Date:12/14/2009)... Pasierb, President ,, NEW YORK, Dec. 14 ... the Future study (MTF) -- the largest survey on ... 12th graders -- underscores that teens, intentional abuse of ... a cause for concern, with an alarming number of ... relatives. ,, Teen Abuse of Medication ...
(Date:12/14/2009)... When Kurth Krause, an aerospace engineer,for NASA, was ... the moon, he,was confident that technology and science ... there was one thing that science couldn,t solve.,His ... though dialysis machines,would keep her alive for awhile, ... wife is 69 and is starting dialysis next ...
(Date:12/14/2009)... A team of scientists from the UC San Diego ... identified a protein switch that helps prevent liver damage, ... a better understanding of how the protein, TAK1, works ... liver disease and cancer. , "TAK1 appears to ... A. Brenner, MD, professor of medicine and Dean of ...
(Date:12/14/2009)... meth and smoking, but concerns about prescription abuse, ... Fewer teenagers are using methamphetamine, but reductions in ... drugs remains high, U.S. health officials report. , ... as the hallucinogenic salvia leaf and the prescription ... attention-deficit hyperactivity disorder (ADHD), appear to be gaining ...
(Date:12/14/2009)... YORK, Dec. 14 Concetta F. Conkling of Moraga, ... San Francisco, CA, has been elected Chair of the ... Blind (AFB) -- the nearly 90-year-old organization to which Helen ... Headquartered in New York with offices in San ... Huntington, WV, AFB is dedicated to expanding possibilities for ...
Breaking Medicine News(10 mins):Health News:Partnership for a Drug-Free America(R) Responds to 2009 Monitoring the Future Study Results 2Health News:Partnership for a Drug-Free America(R) Responds to 2009 Monitoring the Future Study Results 3Health News:69-Year-Old Grandmother Needing A Lifesaving Kidney Transplant Finds a Miracle on the Internet: a 25-Year-Old Living Altruistic Organ Donor Stranger 2Health News:69-Year-Old Grandmother Needing A Lifesaving Kidney Transplant Finds a Miracle on the Internet: a 25-Year-Old Living Altruistic Organ Donor Stranger 3Health News:Scientists uncover protective mechanism against liver cancer 2Health News:Marijuana Use No Longer Dropping Among U.S. Teens 2Health News:Marijuana Use No Longer Dropping Among U.S. Teens 3Health News:Marijuana Use No Longer Dropping Among U.S. Teens 4Health News:The American Foundation for the Blind Welcomes New Board Chair, Concetta F. Conkling 2
... of the journal Nature on December 6, 2007, furthers the ... can detect and respond to specific cues in of a ... really exciting starting place for us to understand how pheromones ... Stowers of the Scripps Research Department of Cell Biology. , ...
... molecules pulls certain types of,defective proteins out of the ... new cancer drugs, MEMPHIS, Tenn., Dec. 6 ... new insights into how,myeloma cells dispose of defective or ... The researchers identified key cellular components that carry out,protein ...
... unhappy child on Christmas ... keeping family harmony, CINCINNATI, Dec. 6 As they,re ... shelves for toys they,think are safe, now parents have a ... are disappointed because the unsafe toy they wanted,isn,t under the ...
... lead to new treatments for schizophrenia , THURSDAY, Dec. ... out how the drug ketamine impairs the brain, a ... schizophrenia. , The anesthetic/antidepressant triggers increased production of a ... drug users, but that action can be blocked, say ...
... depression, anxiety disorders, researchers say , THURSDAY, Dec. 6 ... Parkinson,s disease are at increased risk for depression and ... particularly high in the brothers, sisters, parents and children ... a team from the Mayo Clinic in Rochester, Minn. ...
... Kissing in Coach, CHICAGO, Dec. 6 The ... of screaming kids with colds,cancelled flights and less-than-enthused flight ... cart. But holiday travel isn,t all bad news.,With AXE,s ... which was,announced today, you can easily identify the airports ...
Other Medicine News:Health News:Scripps research scientists discover chemical triggers for aggression in mice 2Health News:Scripps research scientists discover chemical triggers for aggression in mice 3Health News:St. Jude Finds Mechanism for Faulty Protein Disposal 2Health News:Concern Over Toy Safety and Disappointed Kids Impacts Holidays for Parents 2Health News:Concern Over Toy Safety and Disappointed Kids Impacts Holidays for Parents 3Health News:Ketamine Impairs Brain by Releasing Superoxide 2Health News:Relatives of Parkinson's Patients at Higher Psychiatric Risk 2Health News:Philly International Airport Tops 'AXE's Best and Worst Airports to Make a Connection' 2Health News:Philly International Airport Tops 'AXE's Best and Worst Airports to Make a Connection' 3Health News:Philly International Airport Tops 'AXE's Best and Worst Airports to Make a Connection' 4Health News:Philly International Airport Tops 'AXE's Best and Worst Airports to Make a Connection' 5
(Date:12/14/2009)... -- Environmental health advocates hope that U.S. FDA ... of bisphenol A (BPA), a synthetic sex hormone ... other illnesses, in time for Christmas. ,, ... scientist, Natural Resources Defense Council : "Just ... advice, FDA must rely on the advice of ...
(Date:12/14/2009)... patients in Finland have gained access to more ... technology from Varian Medical Systems (NYSE: ... in the Nordic region. Clinicians at Docrates Clinic ... form of radiotherapy to treat patients with multiple ... prostate. ,, RapidArc, which enables clinicians to deliver ...
(Date:12/14/2009)... Incorporated (Nasdaq: ARAY ), a global leader ... the first CyberKnife® Robotic Radiosurgery System in Belgium ... Liege. ,, The University Hospital in Liege, ... hospitals in Euregio, a cross-country region of 18 ... of cancer treatments, University Hospital of Liege is ...
Breaking Medicine Technology:Toxic Chemical bisphenol A Still Not Banned By FDA; Schumer, Gillibrand Call for Ban; Govt Official Warns Public 2Cancer Patients in Finland Gain Access to Advanced RapidArc Radiotherapy Treatments 2Cancer Patients in Finland Gain Access to Advanced RapidArc Radiotherapy Treatments 3First CyberKnife in Belgium to be Installed at Leading University Hospital 2First CyberKnife in Belgium to be Installed at Leading University Hospital 3Study Evaluating Efficacy and Safety of Two Low dose Regimens of PREMARIN Vaginal Cream for the Treatment of Moderate to Severe Vaginal Atrophy Now Pu 51467 1Study Evaluating Efficacy and Safety of Two Low dose Regimens of PREMARIN Vaginal Cream for the Treatment of Moderate to Severe Vaginal Atrophy Now Pu 51467 2Study Evaluating Efficacy and Safety of Two Low dose Regimens of PREMARIN Vaginal Cream for the Treatment of Moderate to Severe Vaginal Atrophy Now Pu 51467 3Study Evaluating Efficacy and Safety of Two Low dose Regimens of PREMARIN Vaginal Cream for the Treatment of Moderate to Severe Vaginal Atrophy Now Pu 51467 4Study Evaluating Efficacy and Safety of Two Low dose Regimens of PREMARIN Vaginal Cream for the Treatment of Moderate to Severe Vaginal Atrophy Now Pu 51467 5Study Evaluating Efficacy and Safety of Two Low dose Regimens of PREMARIN Vaginal Cream for the Treatment of Moderate to Severe Vaginal Atrophy Now Pu 51467 6Sparta Systems TrackWise 28R 29 Solution Delivers Workforce Training and Learning Initiatives for Cangene Corporation 12990 1Sparta Systems TrackWise 28R 29 Solution Delivers Workforce Training and Learning Initiatives for Cangene Corporation 12990 2Sparta Systems TrackWise 28R 29 Solution Delivers Workforce Training and Learning Initiatives for Cangene Corporation 12990 3Sparta Systems TrackWise 28R 29 Solution Delivers Workforce Training and Learning Initiatives for Cangene Corporation 12990 4Childhood obesity link to parents 51461 1
... - Over 1,500 U.S. patients enrolled in study examining potential ... ,GI-friendly, treatment for mild to moderate pain - ... expected in second half of 2008 -, PALO ALTO, ... company, today announced that it is,closing enrollment in its two ...
... Calif., Feb. 11 Pharmacyclics,Inc. (Nasdaq: ... characterizing the,company,s novel highly-selective histone deacetylase (HDAC) ... 8 (HDAC8)-specific inhibitor,PCI-34051 induces apoptosis in T-cell ... Leukemia., Histone deacetylases are a family ...
Other Medicine Technology:Horizon Therapeutics Completes Enrollment in Phase 3 Trials for Lead Product Candidate HZT-501 2Horizon Therapeutics Completes Enrollment in Phase 3 Trials for Lead Product Candidate HZT-501 3Pharmacyclics Announces Data and Publication Characterizing Highly-Selective HDAC Inhibitor 2Pharmacyclics Announces Data and Publication Characterizing Highly-Selective HDAC Inhibitor 3
... This remarkable anti-reflux valve ... plastic housing which prevents the ... closed when in sitting or ... virtually self-cleaning and interference free ...
... valve is enclosed in a ... the valve from being accidentally ... or reclining positions. The valve ... free ensuring uninterrupted flow and ...
... remarkable anti-reflux valve is enclosed ... which prevents the valve from ... in sitting or reclining positions. ... and interference free ensuring uninterrupted ...
... The VerifyNow (Ultegra) System is a ... measures platelet induced aggregation as an ... consists of an instrument, a disposable ... device contains reagents based on microbead ...
Medicine Products: